Suppr超能文献

针对普通人群皮肤癌分诊的移动健康应用程序:一项关于医疗服务提供者观点的定性研究

Mobile health apps for skin cancer triage in the general population: a qualitative study on healthcare providers' perspectives.

作者信息

Sangers Tobias E, Wakkee Marlies, Moolenburgh Folkert, Nijsten Tamar, Lugtenberg Marjolein

机构信息

Department of Dermatology, Erasmus MC Cancer Institute, University Medical Center Rotterdam, Rotterdam, 3015 GD, The Netherlands.

Department of Dermatology, Leiden University Medical Center, Leiden, The Netherlands.

出版信息

BMC Cancer. 2025 May 9;25(1):851. doi: 10.1186/s12885-025-14244-3.

Abstract

BACKGROUND

Mobile health (mHealth) applications (apps) integrated with artificial intelligence for skin cancer triage are increasingly available to the general public. Nevertheless, their actual uptake is limited. Although endorsement by healthcare providers (HCPs) is one of the perceived facilitators for using this technology, the perceptions of key HCPs in skin cancer triage towards those apps have not been studied.

OBJECTIVES

To explore key HCPs' perceived risks, benefits, and preconditions for endorsement of mHealth apps for skin cancer triage in the general population.

METHODS

An in-depth qualitative online focus group (FG) study was conducted consisting of six focus groups: three with dermatologists and three with general practitioners (GPs). Dutch dermatologists and GPs were selected using purposive sampling based on age, knowledge and previous experience with AI. A total of sixteen dermatologists and seventeen GPs attended 90-minute FGs. Data were analyzed by a multidisciplinary team in a thorough thematic content analysis using multiple phases of coding derived from Grounded Theory.

RESULTS

A total of four main risks, three main benefits, and four main preconditions for endorsement were identified. Risks perceived by HCPs concerned incorrect diagnoses, exclusion of subpopulations, and loss of GP autonomy in clinical decision making and diagnostic experience. Perceived benefits were increased skin cancer awareness, facilitation of the early detection of skin cancer, and a streamlined patient journey. Preconditions for endorsement were evidence-based verification of accuracy, integration in clinical practice, clarity about liability in case of adverse events, and accessible and inclusive app design.

CONCLUSIONS

Although HCPs perceive pivotal risks related to the implementation of mHealth apps, they also foresee important benefits when implemented successfully. In order for HCPs to endorse those apps, emphasis must be placed on integrating accurate mHealth apps with accessible and inclusive design and functionality into clinical practice, factors that currently appear to be largely unmet.

摘要

背景

与人工智能集成用于皮肤癌分诊的移动健康(mHealth)应用程序(应用)越来越多地向公众提供。然而,它们的实际使用情况有限。尽管医疗保健提供者(HCPs)的认可被认为是使用这项技术的促进因素之一,但关键HCPs在皮肤癌分诊中对这些应用的看法尚未得到研究。

目的

探讨关键HCPs对一般人群中用于皮肤癌分诊的mHealth应用的感知风险、益处和认可的先决条件。

方法

进行了一项深入的定性在线焦点小组(FG)研究,包括六个焦点小组:三个由皮肤科医生组成,三个由全科医生(GPs)组成。根据年龄、知识和以前使用人工智能的经验,采用目的抽样法选择荷兰皮肤科医生和全科医生。共有16名皮肤科医生和17名全科医生参加了90分钟的焦点小组讨论。一个多学科团队使用扎根理论衍生的多阶段编码,对数据进行了全面的主题内容分析。

结果

共确定了四个主要风险、三个主要益处和四个认可的主要先决条件。HCPs感知到的风险涉及错误诊断、亚人群排除以及全科医生在临床决策和诊断经验方面自主权的丧失。感知到的益处是提高皮肤癌意识、促进皮肤癌的早期检测以及简化患者就医流程。认可的先决条件是基于证据的准确性验证、融入临床实践、不良事件情况下责任的明确以及可访问和包容性的应用设计。

结论

尽管HCPs认识到与mHealth应用实施相关的关键风险,但他们也预见到成功实施时的重要益处。为了让HCPs认可这些应用,必须强调将具有可访问和包容性设计及功能的准确mHealth应用融入临床实践,而目前这些因素在很大程度上似乎尚未得到满足。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e5f9/12065202/28609b3f2ff3/12885_2025_14244_Fig1_HTML.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验